Chemical Name:4,6-Dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]-
1H-indole-2-carboxylic acid sodium salt
Biological Activity:
Highly
potent and selective non-competitive antagonist acting at the
strychnine-insensitive glycine binding site of the NMDA receptor-channel
complex (Kd = 0.8 nM). Displays > 1000-fold selectivity over
NMDA, AMPA and kainate binding sites. Orally bioavailable and active in vivo.
Di Fabioet al
(1997) Substituted indole-2-carboxylates as in vivo potent antagonists
acting at the strychnine-insensitive glycine binding site. J.Med.Chem. 40
841. Mugnaini et al (2000) Receptor binding characteristics of
the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat
cerebral cortical membranes. Eur.J.Pharmacol. 391 233. Kajbaf et
al (2003) Pharmacokinetics, metabolism and excretion of the glycine
antagonist GV150526A in rat and dog. Xenobiotica. 33 415.
Keywords: Gavestinel, Ligand-gated Ion Channels, Potent & Selective Glycine Site Antagonist. Orally Available & Active In Vivo, GV 150526A, Tocris Bioscience
Literature in this Area
Scientific Reviews
The Ins & outs of Glutamate Transporter Pharmacology Download PDF
Signal Transduction Guide
A complete listing of signal transduction products available from Tocris, including descriptions on selected tools and unit sizes.